![](/img/cover-not-exists.png)
A redox ruthenium compound directly targets PHD2 and inhibits the HIF1 pathway to reduce tumor angiogenesis independently of p53
Vidimar, Vania, Licona, Cynthia, Camacho, Ricardo Cerón, Guerin, Eric, Coliat, Pierre, Venkatasamy, Aina, Ali, Moussa, Guenot, Dominique, Le Lagadec, Ronan, Jung, Alain C., Freund, Jean-Noel, Pfeffer,Language:
english
Journal:
Cancer Letters
DOI:
10.1016/j.canlet.2018.09.029
Date:
October, 2018
File:
PDF, 4.65 MB
english, 2018